December 14, 2018 Bayer and the S M Sehgal Foundation announce a new project:Supporting livelihoods and nutrition of smallholder farmers in IndiaRead more
SPECIALIZED PRESS December 12, 2018 Increased focus on calf health:Bayer Animal Health and ParaTheraTech sign global license agreementBayer to strengthen its portfolio of products for farm animals with new Cryptosporidiosis treatment options derived from ParaTheraTech ...Read more
SPECIALIZED PRESS December 10, 2018 Bayer helps farmers keep sows healthy with new BCS SowDition smartphone applicationBCS SowDition enables accurate and standardized body condition scoring of sows in four simple steps, contributing to better health and management ...Read more
December 7, 2018 First Anniversary of Bayer’s Transparency InitiativeBayer committed to transparency: Posts more than 300 glyphosate safety study summaries onlineRead more
December 5, 2018 Capital Markets Day 2018Bayer to drive value creation as company pursues ambitious growth targets through 2022Company strongly positioned to benefit from key megatrends / ...Read more
December 3, 2018 Chronic Thromboembolic Pulmonary Hypertension (CTEPH)FDA grants breakthrough device designation to artificial intelligence software for CTEPH pattern recognition from Bayer and MSDThe software in development intends to support clinical decision-making of chronic thromboembolic pulmonary hypertension – a progressive and life-threatening condition ...Read more
PRESS KIT November 29, 2018 Group to take comprehensive range of portfolio, efficiency and structural measuresBayer to strengthen core life science businesses while significantly enhancing productivity and profitabilityRead more
November 29, 2018 Group to take comprehensive range of portfolio, efficiency and structural measuresBayer to strengthen core life science businesses while significantly enhancing productivity and profitabilityGroup plans to exit Animal Health business, the Consumer Health brands Coppertone™ and Dr. Scholl’s™, and sell its 60-percent interest in Currenta, a site services provider in Germany ...Read more
SPECIALIZED PRESS November 27, 2018 Not intended for U.S. and UK MediaBayer receives EU approval for its hemophilia A treatment Jivi®The safety and efficacy profile of Jivi has been demonstrated in more than five years of clinical studies ...Read more
.jpg)
